Table of Contents Author Guidelines Submit a Manuscript
Obstetrics and Gynecology International
Volume 2016 (2016), Article ID 6870679, 6 pages
http://dx.doi.org/10.1155/2016/6870679
Research Article

Knowledge of Latin American Obstetricians and Gynecologists regarding Heavy Menstrual Bleeding

1Department of Obstetrics and Gynecology, University of Campinas Medical School (UNICAMP), Campinas, SP, Brazil
2Bayer HealthCare, Mexico City, Mexico
3Hospital Italiano, Buenos Aires, Argentina
4Federal University of Minas Gerais, Belo Horizonte, MG, Brazil
5Florida International University College of Medicine, Miami, Fl, USA

Received 28 June 2016; Revised 24 July 2016; Accepted 28 July 2016

Academic Editor: W. T. Creasman

Copyright © 2016 Luis Bahamondes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background. Heavy menstrual bleeding (HMB) is a common gynecological complaint affecting quality of life. Objectives. To assess knowledge on diagnosis and treatments of HMB of Latin American (LA) obstetricians and gynecologists (OBGYNs). Methods. A survey was conducted during a scientific meeting, organized to provide updated information on topics of reproductive medicine to OBGYNs from 12 LA countries who were invited to respond to a multiple-choice questionnaire. Results. Of the 210 OBGYNs participating in the survey, from 169 (80.4%) to 203 (96.7%) answered the questions. Most respondents (80%) gave accurate answers regarding the amount of blood loss which defines HMB, underreported the proportion of women who consulted due to HMB, and were aware that the use of combined oral contraceptives (COCs) with ethynyl estradiol is not an adequate treatment in women with HMB. Female OBGYNs and those who worked in the private sector were more prone to report a higher possibility of improvement of HMB with a COC that contained estradiol valerate and dienogest or with a levonorgestrel-releasing intrauterine system. Conclusions. In general, the respondents were aware of the importance of HMB in gynecological practice and of the new medical treatments and underreported the proportion of women who consulted due to HMB.